Elevated non-HDL-C linked to higher mortality in patients undergoing peritoneal dialysis: Study

· During the follow-up period, 31.4% patients died, of which 49.0% were due to CV events.

· Atherosclerotic CV mortality accounted for 59.8% of CV mortality.

· In multivariable models, for 1-SD increase in non-HDL-C level, the hazard ratios (HRs) for CV and all-cause mortality were 1.52 and 1.24 respectively.

· Non-HDL-C was positively associated with atherosclerotic CV mortality (HR, 1.29) but not associated with nonatherosclerotic CV mortality (HR, 0.79).

· The quartile analyses showed a similar pattern to the continuous variable analyses of non-HDL-C levels for CV and all-cause mortality but did not demonstrate statistical significance for atherosclerotic or nonatherosclerotic CV mortality. 

"Our findings demonstrated that an elevated non-HDL-C level was independently associated with an increased risk of CV mortality, especially atherosclerotic CV mortality, and all-cause mortality in incident PD patients," concluded the authors.